165 related articles for article (PubMed ID: 11108730)
1. Modulation of hepatic lipoprotein synthesis and secretion by taxifolin, a plant flavonoid.
Theriault A; Wang Q; Van Iderstine SC; Chen B; Franke AA; Adeli K
J Lipid Res; 2000 Dec; 41(12):1969-79. PubMed ID: 11108730
[TBL] [Abstract][Full Text] [Related]
2. Differential regulation of apolipoprotein B secretion from HepG2 cells by two HMG-CoA reductase inhibitors, atorvastatin and simvastatin.
Wilcox LJ; Barrett PH; Huff MW
J Lipid Res; 1999 Jun; 40(6):1078-89. PubMed ID: 10357840
[TBL] [Abstract][Full Text] [Related]
3. Effect of ethanol on the synthesis and secretion of apoA-I- and apoB-containing lipoproteins in HepG2 cells.
Dashti N; Franklin FA; Abrahamson DR
J Lipid Res; 1996 Apr; 37(4):810-24. PubMed ID: 8732781
[TBL] [Abstract][Full Text] [Related]
4. Effects of atorvastatin on the intracellular stability and secretion of apolipoprotein B in HepG2 cells.
Mohammadi A; Macri J; Newton R; Romain T; Dulay D; Adeli K
Arterioscler Thromb Vasc Biol; 1998 May; 18(5):783-93. PubMed ID: 9598838
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of HMG-CoA reductase by atorvastatin decreases both VLDL and LDL apolipoprotein B production in miniature pigs.
Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2589-600. PubMed ID: 9409231
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and secretion of B-100 and A-I apolipoproteins in response to the changes of intracellular cholesteryl ester content in chick liver.
Tarugi P; Nicolini S; Ballarini G; Marchi L; Duvigneau C; Tartoni P; Calandra S
J Lipid Res; 1996 Mar; 37(3):493-507. PubMed ID: 8728313
[TBL] [Abstract][Full Text] [Related]
7. Secretion of apolipoproteins A-I and B by HepG2 cells: regulation by substrates and metabolic inhibitors.
Kempen HJ; Imbach AP; Giller T; Neumann WJ; Hennes U; Nakada N
J Lipid Res; 1995 Aug; 36(8):1796-806. PubMed ID: 7595100
[TBL] [Abstract][Full Text] [Related]
8. Microsomal triacylglycerol transfer protein prevents presecretory degradation of apolipoprotein B-100. A dithiothreitol-sensitive protease is involved.
Benoist F; Nicodeme E; Grand-Perret T
Eur J Biochem; 1996 Sep; 240(3):713-20. PubMed ID: 8856075
[TBL] [Abstract][Full Text] [Related]
9. Octanoate reduces very low-density lipoprotein secretion by decreasing the synthesis of apolipoprotein B in primary cultures of chicken hepatocytes.
Tachibana S; Sato K; Cho Y; Chiba T; Schneider WJ; Akiba Y
Biochim Biophys Acta; 2005 Oct; 1737(1):36-43. PubMed ID: 16226916
[TBL] [Abstract][Full Text] [Related]
10. Conformational changes in apolipoprotein B modulate intracellular assembly and degradation of ApoB-containing lipoprotein particles in HepG2 cells.
Macri J; Adeli K
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2982-94. PubMed ID: 9409285
[TBL] [Abstract][Full Text] [Related]
11. Cotranslational inhibition of apoB-100 synthesis by cyclosporin A in the human hepatoma cell line HepG2.
Kaptein A; de Wit EC; Princen HM
Arterioscler Thromb; 1994 May; 14(5):780-9. PubMed ID: 8172854
[TBL] [Abstract][Full Text] [Related]
12. An inhibitor of squalene epoxidase, NB-598, suppresses the secretion of cholesterol and triacylglycerol and simultaneously reduces apolipoprotein B in HepG2 cells.
Horie M; Hayashi M; Satoh T; Hotta H; Nagata Y; Ishida F; Kamei T
Biochim Biophys Acta; 1993 May; 1168(1):45-51. PubMed ID: 8504141
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of apolipoprotein B secretion by taurocholate is controlled by the N-terminal end of the protein in rat hepatoma McArdle-RH7777 cells.
Elzinga BM; Baller JF; Mensenkamp AR; Yao Z; Agellon LB; Kuipers F; Verkade HJ
Biochim Biophys Acta; 2003 Dec; 1635(2-3):93-103. PubMed ID: 14729072
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory activity of diacylglycerol acyltransferase (DGAT) and microsomal triglyceride transfer protein (MTP) by the flavonoid, taxifolin, in HepG2 cells: potential role in the regulation of apolipoprotein B secretion.
Casaschi A; Rubio BK; Maiyoh GK; Theriault AG
Atherosclerosis; 2004 Oct; 176(2):247-53. PubMed ID: 15380446
[TBL] [Abstract][Full Text] [Related]
15. Effects of gamma-tocotrienol on ApoB synthesis, degradation, and secretion in HepG2 cells.
Theriault A; Wang Q; Gapor A; Adeli K
Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):704-12. PubMed ID: 10073977
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of hydroxymethylglutaryl coenzyme A reductase activity does not affect the secretion rate of apolipoproteins B and AI by CaCo-2 cells.
Pau E; He Y; Lougheed M; Steinbrecher UP
Biochem Cell Biol; 1995; 73(1-2):81-90. PubMed ID: 7662319
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of hepatocyte apoB secretion by naringenin: enhanced rapid intracellular degradation independent of reduced microsomal cholesteryl esters.
Borradaile NM; de Dreu LE; Barrett PH; Huff MW
J Lipid Res; 2002 Sep; 43(9):1544-54. PubMed ID: 12235187
[TBL] [Abstract][Full Text] [Related]
18. ApoB100 secretion from HepG2 cells is decreased by the ACAT inhibitor CI-1011: an effect associated with enhanced intracellular degradation of ApoB.
Wilcox LJ; Barrett PH; Newton RS; Huff MW
Arterioscler Thromb Vasc Biol; 1999 Apr; 19(4):939-49. PubMed ID: 10195921
[TBL] [Abstract][Full Text] [Related]
19. The magnitude of decrease in hepatic very low density lipoprotein apolipoprotein B secretion is determined by the extent of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition in miniature pigs.
Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
Endocrinology; 1999 Nov; 140(11):5293-302. PubMed ID: 10537160
[TBL] [Abstract][Full Text] [Related]
20. The effect of low density lipoproteins, cholesterol, and 25-hydroxycholesterol on apolipoprotein B gene expression in HepG2 cells.
Dashti N
J Biol Chem; 1992 Apr; 267(10):7160-9. PubMed ID: 1313035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]